Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.
Krogh-Madsen M, Bender B, Jensen MK, Nielsen OJ, Friberg LE, Honoré PH.
Cancer Chemother Pharmacol. 2012 May;69(5):1155-63. Epub 2012 Jan 3.
Related citations
Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi N, Miura M, Niioka T, Sawada K.
Cancer Chemother Pharmacol. 2012 Apr;69(4):999-1004. Epub 2011 Dec 7.
MTHFR 677TT genotype and toxicity of methotrexate: controversial results.
Lopez-Lopez E, Ballesteros J, Garcia-Orad A.
Cancer Chemother Pharmacol. 2011 Nov;68(5):1369-70; author reply 1371. Epub 2011 Aug 6. No abstract available.
Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V, Ramaglia M, Iannotta A, Crisci S, Indolfi P, Francese M, Affinita MC, Pecoraro G, Napolitano A, Fusco C, Oreste M, Indolfi C, Casale F.
Cancer Chemother Pharmacol. 2011 Nov;68(5):1339-46. Epub 2011 May 18.
Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.
Weiss J, Haefeli WE.
Cancer Chemother Pharmacol. 2011 Oct;68(4):1093-8. Epub 2011 Jul 31.
Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
Albayrak M, Konyssova U, Kaya Z, Gursel T, Guntekin S, Percin EF, Kocak U.
Cancer Chemother Pharmacol. 2011 Nov;68(5):1155-9. Epub 2011 Mar 13.
The role of imatinib plasma level testing in gastrointestinal stromal tumor.
George S, Trent JC.
Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S45-50. Epub 2010 Dec 8. Review.
A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Hebb J, Assouline S, Rousseau C, Desjardins P, Caplan S, Egorin MJ, Amrein L, Aloyz R, Panasci L.
Cancer Chemother Pharmacol. 2011 Sep;68(3):643-51. Epub 2010 Dec 1.
Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.
Scatena CD, Kumer JL, Arbitrario JP, Howlett AR, Hawtin RE, Fox JA, Silverman JA.
Cancer Chemother Pharmacol. 2010 Oct;66(5):881-8. Epub 2010 Jan 8.
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.
Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel D, Vendrell JA, Dumontet C.
Cancer Chemother Pharmacol. 2011 Jul;68(1):97-105. Epub 2010 Sep 16.
Corchorusin-D, a saikosaponin-like compound isolated from Corchorus acutangulus Lam., targets mitochondrial apoptotic pathways in leukemic cell lines (HL-60 and U937).
Mallick S, Ghosh P, Samanta SK, Kinra S, Pal BC, Gomes A, Vedasiromoni JR.
Cancer Chemother Pharmacol. 2010 Sep;66(4):709-19. Epub 2009 Dec 24.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on